Closure of the WATCHMAN LAA System May Provide an Alternative to Warfarin in Patients with Nonvalvular AF

Article Figures & Data

Figures

  • Figure 1.

    WATCHMAN Rates of All-Cause Stroke and All-Cause Mortality Were Noninferior to Warfarin in the PROTECT AF Trial.

    CV=cardiovascular; PROTECT AF=WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation.
  • The editors would like to thank the many members of the CardioAlex 2012 presenting faculty who generously gave their time to ensure the accuracy and quality of the articles in this publication.